• Wed news: Novo and Viking heat up MASH space. New Pfizer R&D chief. Trump and the Biosecure Act. Sage Huntington’s prospect flunks trial. Dr. Oz to run CMS. See more on our front page

Tanking Stock





































































Interesting. Thanks.
Can’t believe that I am actually praying this deal with Crown goes through as the Prollenium option is even worse. Prollenium is so desperate that they are willing to pay more than the original price Crown offered, but the PE that owns Prollenium is not supportive. Why? Because the PE knows it is a sinking ship. So let’s stay positive and hope Crown takes over.
 




Hey look in the bright side, with all the Versa people leaving there are options. I hear they are launching some fish sperm topical shit and maybe some exosomes next year. If they could somehow mix dog shit with HA and sell it they would and call it innovative. But still better than this shit box we are trapped in.
Prollenium’s turnover is worse than Galderma’s. Hey, better have fish sperm on your face than shady matk wilkins’.
 




Prollenium’s turnover is worse than Galderma’s. Hey, better have fish sperm on your face than shady matk wilkins’.
You all are on a sinking ship and trying to talk shit about a company that doesn’t have to spend $3 to make $1? Now you have no money and no loyalty and nobody wants you…but it’s the other companies that are bad.